Copyright
©The Author(s) 2015.
World J Gastroenterol. May 7, 2015; 21(17): 5287-5294
Published online May 7, 2015. doi: 10.3748/wjg.v21.i17.5287
Published online May 7, 2015. doi: 10.3748/wjg.v21.i17.5287
Variable | Non suitable for surgical resection(n = 100) | Suitable for surgical resection(n = 84) | P value |
Age (yr) | 76 (36-88) | 52 (32-74) | 0.015 |
Gender | |||
Male/female | 70 (70.0)/30 (30.0) | 58 (69.0)/26 (31.0) | 0.889 |
Pre-existing hepatitis | |||
Hepatitis B | 87 (87.0) | 66 (78.5) | 0.128 |
Hepatitis C | 9 (9.0) | 6 (7.1) | 0.647 |
Hepatitis B and C | 2 (2.0) | 1 (1.2) | 1.000 |
Others | 2 (2.0) | 1 (1.2) | 1.000 |
Child-Pugh grade | 0.000 | ||
Class A/class B | 51 (51.0)/49 (49.0) | 84(100)/ 0 (0) | |
Portal hypertension | 84 (84.0) | 0 (0) | 0.000 |
AFP (ng/mL) | 50.8 (2-240) | 68.7 (4-300) | 0.188 |
Tumor diameter (cm) | 2.5 (1.1-3.0) | 2.6 (1.0-3.0) | 0.608 |
Location of tumor (S1/S2/S3/S4/S5/S6/S7/S8) | 1/9/5/12/15/18/21/19 | 2/7/5/9/13/16/18/14 | 0.997 |
Subcapsular location | 0.401 | ||
Yes/no | 43 (43.0)/57 (57.0) | 31 (36.9)/53 (63.1) | |
Approach of the first ablation session | 0.401 | ||
Percutanous | 57 (57.0) | 53 (63.1) | |
Laparoscopic | 43 (43.0) | 31 (36.9) |
Significant variable | Univariate analysis | Multivariate analysis | ||
OR (95%CI) | P value | OR (95%CI) | P value | |
Age (> 65 yr), yes/no | 1.141 (0.735-1.724) | 0.034 | 1.057 (0.787-1.587) | 0.097 |
Gender (male), yes/no | 0.980 (0.545-1.763) | 0.947 | ||
Tumor size (> 2.0 cm/ ≤ 2.0 cm) | 1.001 (0.754-1.328) | 0.994 | ||
Child-Pugh grade (class A/B) | 0.976 (0.438-2.177) | 0.954 | ||
AFP (> 20 ng/mL/ ≤ 20 ng/mL) | 1.031 (0.726-2.041) | 0.342 | ||
Hepatitis B (yes/no) | 1.070 (0.557-2.054) | 0.839 | ||
Hepatitis C (yes/no) | 0.596 (0.252-1.412 | 0.240 | ||
Hepatitis B and C (yes/no) | 0.596 (0.252-1.412) | 0.240 | ||
Portal hypertension (yes/no) | 2.847 (1.819-4.458) | 0.015 | 2.089(1.387-2.958) | 0.027 |
Total bilirubin (< 1.5 mg/dL/≥ 1.5 mg/dL) | 3.023 (1.632-5.600) | 0.006 | 1.556 (1.827-2.965) | 0.028 |
Approach of the first ablation session (laparoscopic) (yes/no) | 1.205 (0.678-2.231) | 0.068 |
- Citation: Gao J, Wang SH, Ding XM, Sun WB, Li XL, Xin ZH, Ning CM, Guo SG. Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment. World J Gastroenterol 2015; 21(17): 5287-5294
- URL: https://www.wjgnet.com/1007-9327/full/v21/i17/5287.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i17.5287